Global Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Research Report 2023

Publication ID:

PB504247705

Publication Date:

May 8, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Extracorporeal Cardiopulmonary Support Assist System market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Extracorporeal Cardiopulmonary Support Assist System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Extracorporeal Cardiopulmonary Support Assist System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Extracorporeal Cardiopulmonary Support Assist System include Medtronic, Getinge (Maquet), LivaNova (Sorin), Terumo, Fresenius Medical Care and Beijing Medos AT Biotechnology Co., Ltd., etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Extracorporeal Cardiopulmonary Support Assist System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracorporeal Cardiopulmonary Support Assist System.
The Extracorporeal Cardiopulmonary Support Assist System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Extracorporeal Cardiopulmonary Support Assist System market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extracorporeal Cardiopulmonary Support Assist System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Medtronic
Getinge (Maquet)
LivaNova (Sorin)
Terumo
Fresenius Medical Care
Beijing Medos AT Biotechnology Co., Ltd.
Segment by Type
Cardiopulmonary Bypass Pump
Cardiopulmonary Bypass Monitoring Device
Cardiopulmonary Bypass Control Device
Segment by Application
Cardiopulmonary Bypass Surgery
Long-term Cardiopulmonary Support
First Aid
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Extracorporeal Cardiopulmonary Support Assist System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Extracorporeal Cardiopulmonary Support Assist System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Overview
1.1 Product Overview and Scope of Extracorporeal Cardiopulmonary Support Assist System
1.2 Extracorporeal Cardiopulmonary Support Assist System Segment by Type
1.2.1 Global Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Cardiopulmonary Bypass Pump
1.2.3 Cardiopulmonary Bypass Monitoring Device
1.2.4 Cardiopulmonary Bypass Control Device
1.3 Extracorporeal Cardiopulmonary Support Assist System Segment by Application
1.3.1 Global Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Value by Application: (2023-2029)
1.3.2 Cardiopulmonary Bypass Surgery
1.3.3 Long-term Cardiopulmonary Support
1.3.4 First Aid
1.3.5 Other
1.4 Global Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Extracorporeal Cardiopulmonary Support Assist System Revenue 2018-2029
1.4.2 Global Extracorporeal Cardiopulmonary Support Assist System Sales 2018-2029
1.4.3 Global Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Competition by Manufacturers
2.1 Global Extracorporeal Cardiopulmonary Support Assist System Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Extracorporeal Cardiopulmonary Support Assist System Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Extracorporeal Cardiopulmonary Support Assist System Average Price by Manufacturers (2018-2023)
2.4 Global Extracorporeal Cardiopulmonary Support Assist System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Extracorporeal Cardiopulmonary Support Assist System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Extracorporeal Cardiopulmonary Support Assist System, Product Type & Application
2.7 Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Competitive Situation and Trends
2.7.1 Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Extracorporeal Cardiopulmonary Support Assist System Players 麻豆原创 Share by Revenue
2.7.3 Global Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Extracorporeal Cardiopulmonary Support Assist System Retrospective 麻豆原创 Scenario by Region
3.1 Global Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Extracorporeal Cardiopulmonary Support Assist System Global Extracorporeal Cardiopulmonary Support Assist System Sales by Region: 2018-2029
3.2.1 Global Extracorporeal Cardiopulmonary Support Assist System Sales by Region: 2018-2023
3.2.2 Global Extracorporeal Cardiopulmonary Support Assist System Sales by Region: 2024-2029
3.3 Global Extracorporeal Cardiopulmonary Support Assist System Global Extracorporeal Cardiopulmonary Support Assist System Revenue by Region: 2018-2029
3.3.1 Global Extracorporeal Cardiopulmonary Support Assist System Revenue by Region: 2018-2023
3.3.2 Global Extracorporeal Cardiopulmonary Support Assist System Revenue by Region: 2024-2029
3.4 North America Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Facts & Figures by Country
3.4.1 North America Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Extracorporeal Cardiopulmonary Support Assist System Sales by Country (2018-2029)
3.4.3 North America Extracorporeal Cardiopulmonary Support Assist System Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Facts & Figures by Country
3.5.1 Europe Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Extracorporeal Cardiopulmonary Support Assist System Sales by Country (2018-2029)
3.5.3 Europe Extracorporeal Cardiopulmonary Support Assist System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Extracorporeal Cardiopulmonary Support Assist System Sales by Country (2018-2029)
3.6.3 Asia Pacific Extracorporeal Cardiopulmonary Support Assist System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Extracorporeal Cardiopulmonary Support Assist System Sales by Country (2018-2029)
3.7.3 Latin America Extracorporeal Cardiopulmonary Support Assist System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Extracorporeal Cardiopulmonary Support Assist System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Extracorporeal Cardiopulmonary Support Assist System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Extracorporeal Cardiopulmonary Support Assist System Sales by Type (2018-2029)
4.1.1 Global Extracorporeal Cardiopulmonary Support Assist System Sales by Type (2018-2023)
4.1.2 Global Extracorporeal Cardiopulmonary Support Assist System Sales by Type (2024-2029)
4.1.3 Global Extracorporeal Cardiopulmonary Support Assist System Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Extracorporeal Cardiopulmonary Support Assist System Revenue by Type (2018-2029)
4.2.1 Global Extracorporeal Cardiopulmonary Support Assist System Revenue by Type (2018-2023)
4.2.2 Global Extracorporeal Cardiopulmonary Support Assist System Revenue by Type (2024-2029)
4.2.3 Global Extracorporeal Cardiopulmonary Support Assist System Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Extracorporeal Cardiopulmonary Support Assist System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Extracorporeal Cardiopulmonary Support Assist System Sales by Application (2018-2029)
5.1.1 Global Extracorporeal Cardiopulmonary Support Assist System Sales by Application (2018-2023)
5.1.2 Global Extracorporeal Cardiopulmonary Support Assist System Sales by Application (2024-2029)
5.1.3 Global Extracorporeal Cardiopulmonary Support Assist System Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Extracorporeal Cardiopulmonary Support Assist System Revenue by Application (2018-2029)
5.2.1 Global Extracorporeal Cardiopulmonary Support Assist System Revenue by Application (2018-2023)
5.2.2 Global Extracorporeal Cardiopulmonary Support Assist System Revenue by Application (2024-2029)
5.2.3 Global Extracorporeal Cardiopulmonary Support Assist System Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Extracorporeal Cardiopulmonary Support Assist System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Extracorporeal Cardiopulmonary Support Assist System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic Extracorporeal Cardiopulmonary Support Assist System Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Getinge (Maquet)
6.2.1 Getinge (Maquet) Corporation Information
6.2.2 Getinge (Maquet) Description and Business Overview
6.2.3 Getinge (Maquet) Extracorporeal Cardiopulmonary Support Assist System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Getinge (Maquet) Extracorporeal Cardiopulmonary Support Assist System Product Portfolio
6.2.5 Getinge (Maquet) Recent Developments/Updates
6.3 LivaNova (Sorin)
6.3.1 LivaNova (Sorin) Corporation Information
6.3.2 LivaNova (Sorin) Description and Business Overview
6.3.3 LivaNova (Sorin) Extracorporeal Cardiopulmonary Support Assist System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 LivaNova (Sorin) Extracorporeal Cardiopulmonary Support Assist System Product Portfolio
6.3.5 LivaNova (Sorin) Recent Developments/Updates
6.4 Terumo
6.4.1 Terumo Corporation Information
6.4.2 Terumo Description and Business Overview
6.4.3 Terumo Extracorporeal Cardiopulmonary Support Assist System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Terumo Extracorporeal Cardiopulmonary Support Assist System Product Portfolio
6.4.5 Terumo Recent Developments/Updates
6.5 Fresenius Medical Care
6.5.1 Fresenius Medical Care Corporation Information
6.5.2 Fresenius Medical Care Description and Business Overview
6.5.3 Fresenius Medical Care Extracorporeal Cardiopulmonary Support Assist System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Fresenius Medical Care Extracorporeal Cardiopulmonary Support Assist System Product Portfolio
6.5.5 Fresenius Medical Care Recent Developments/Updates
6.6 Beijing Medos AT Biotechnology Co., Ltd.
6.6.1 Beijing Medos AT Biotechnology Co., Ltd. Corporation Information
6.6.2 Beijing Medos AT Biotechnology Co., Ltd. Description and Business Overview
6.6.3 Beijing Medos AT Biotechnology Co., Ltd. Extracorporeal Cardiopulmonary Support Assist System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Beijing Medos AT Biotechnology Co., Ltd. Extracorporeal Cardiopulmonary Support Assist System Product Portfolio
6.6.5 Beijing Medos AT Biotechnology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Extracorporeal Cardiopulmonary Support Assist System Industry Chain Analysis
7.2 Extracorporeal Cardiopulmonary Support Assist System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Extracorporeal Cardiopulmonary Support Assist System Production Mode & Process
7.4 Extracorporeal Cardiopulmonary Support Assist System Sales and 麻豆原创ing
7.4.1 Extracorporeal Cardiopulmonary Support Assist System Sales Channels
7.4.2 Extracorporeal Cardiopulmonary Support Assist System Distributors
7.5 Extracorporeal Cardiopulmonary Support Assist System Customers
8 Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Dynamics
8.1 Extracorporeal Cardiopulmonary Support Assist System Industry Trends
8.2 Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Drivers
8.3 Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Challenges
8.4 Extracorporeal Cardiopulmonary Support Assist System 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Medtronic
Getinge (Maquet)
LivaNova (Sorin)
Terumo
Fresenius Medical Care
Beijing Medos AT Biotechnology Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.